Capital Research Global Investors’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206M | Buy |
13,295,573
+94,569
| +0.7% | +$1.46M | 0.04% | 220 |
|
|
2025
Q1 | $196M | Buy |
13,201,004
+38,491
| +0.3% | +$572K | 0.04% | 222 |
|
|
2024
Q4 | $174M | Buy |
13,162,513
+25,309
| +0.2% | +$335K | 0.04% | 238 |
|
|
2024
Q3 | $187M | Buy |
13,137,204
+10,596
| +0.1% | +$151K | 0.04% | 226 |
|
|
2024
Q2 | $170M | Buy |
13,126,608
+4,678
| +0% | +$60.5K | 0.04% | 233 |
|
|
2024
Q1 | $182M | Sell |
13,121,930
-1,175,875
| -8% | -$16.3M | 0.04% | 235 |
|
|
2023
Q4 | $204M | Buy |
14,297,805
+503,446
| +4% | +$7.18M | 0.05% | 230 |
|
|
2023
Q3 | $213M | Buy |
13,794,359
+6,518
| +0% | +$101K | 0.06% | 220 |
|
|
2023
Q2 | $217M | Buy |
13,787,841
+208,381
| +2% | +$3.27M | 0.06% | 225 |
|
|
2023
Q1 | $224M | Buy |
13,579,460
+10,903,323
| +407% | +$180M | 0.06% | 210 |
|
|
2022
Q4 | $41.7M | Buy |
+2,676,137
| New | +$41.7M | 0.01% | 346 |
|
|
2021
Q1 | – | Sell |
-65,430
| Closed | -$1.19M | – | 439 |
|
|
2020
Q4 | $1.19M | Buy |
65,430
+10,055
| +18% | +$183K | ﹤0.01% | 393 |
|
|
2020
Q3 | $1M | Buy |
55,375
+4,042
| +8% | +$73.3K | ﹤0.01% | 393 |
|
|
2020
Q2 | $930K | Buy |
51,333
+15,672
| +44% | +$284K | ﹤0.01% | 392 |
|
|
2020
Q1 | $557K | Buy |
35,661
+10,615
| +42% | +$166K | ﹤0.01% | 383 |
|
|
2019
Q4 | $492K | Buy |
25,046
+5,490
| +28% | +$108K | ﹤0.01% | 396 |
|
|
2019
Q3 | $339K | Buy |
+19,556
| New | +$339K | ﹤0.01% | 403 |
|